George Dakwar

George Dakwar is an accomplished professional in the field of pharmaceutical sciences with extensive experience in drug delivery and formulation. Currently serving as the Director of the Formulation Platform at CureVac since January 2024, George has previously held positions such as Associate Director and Head of Drug Delivery and Formulation at VaxEquity Ltd, and Senior Scientist in Drug Product Development at eTheRNA Immunotherapies. George's academic background includes a PhD in Pharmaceutical Sciences from Ghent University, a Master's in Medical Science focused on Clinical Pharmacology and Drug Delivery Systems from Ben-Gurion University of the Negev, and a Bachelor's degree in Chemistry and Life Sciences from Hebrew University of Jerusalem. Throughout the career, George has contributed significantly to the field with roles involving research and teaching.